ZBH — Zimmer Biomet Holdings Inc. stock price and chart

Share this page

ZBH

$91.57+3.72%

as of close, Oct 5, 2026

☾ AH $91.57 +3.72%

Zimmer Biomet Holdings Inc.Stock · HealthcareS&P 500 Equal Weight 0.2%S&P 500 0.03%Russell 1000 0.02%Russell 3000 0.02%US Stock Market 0.02%MSCI ACWI 0.02%MSCI World 0.02%

PeersMRNALLYUNHJNJMRKTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEDEDEDED

20162019202120242026

80.090.0100.0110.0120.0130.0140.0150.0160.0170.0010.0M20.0M$91.57

2026-10-05

Price$91.57

MA20$91.11

MA50$93.43

Vol9.2M

What would $1,000 invested in ZBH be worth today? →

ZBH returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $91.57
YTD price return: +1.83%
YTD total return: +2.65%
Next earnings: Nov 4, 2026
Market cap: 17.5B2016-12 20.1B2026-10 17.5B-13.0% over the window
Enterprise value: 24.8B
Shares outstanding: 190.7M2016-06 200M2026-06 190.7M-4.6% over the window
52W low: $79.12
52W high: $106.88
From 52W high: -14.32%
From 52W low: +15.74%
52W range: 45%
Beta: 0.47

Volume

Rel volume: 1.18×
30D volume: 1.9M
30D $ vol: 184.2M

Insider trading

Insider net 1WNo open-market insider purchase or sale with a transaction date in the last 7 days, as filed on Form 4.: none
Insider net 1M0 insider-days of buying (no priced lot) and 1 of selling ($529K) in the last 30 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$529K
Insider net 3M0 insider-days of buying (no priced lot) and 2 of selling ($824K) in the last 91 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$824K
Insider net 1Y0 insider-days of buying (no priced lot) and 5 of selling ($1.6M) in the last 365 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$1.6M

Form 4 transactions by trade date, as filed; latest on file 2026-09-11.

Fundamentals

Sales (ttm): 8.5B2016-12 7.7B2026-06 8.5B+11.0% over the window
Sales/share: $44.612016-12 $38.132026-06 $44.61+17.0% over the window
EPS (ttm): $4.112016-06 $1.112026-06 $4.11+270.2% over the window
FCF (ttm): 1.5B2016-06 1B2026-06 1.5B+46.9% over the window
FCF/share: $7.982016-06 $5.182026-06 $7.98+54.0% over the window
Book value/share: $66.182016-06 $47.742026-06 $66.18+38.6% over the window
Net margin: 9.48%2016-12 4.0%2026-06 9.5%+137.6% over the window
ROE: 6.39%2016-06 2.4%2026-06 6.4%+169.1% over the window
ROA: 3.54%2016-06 0.9%2026-06 3.5%+305.3% over the window
Debt / equity: 0.50×2016-06 1.102026-06 0.50-54.9% over the window
Current ratio: 1.692016-06 2.402026-06 1.69-29.6% over the window

Growth (CAGR, ttm) · 10Y

Sales: +8.62%2025-06-30 → 2026-06-307.8B → 8.5B (+8.6% total)+5.75%2023-06-30 → 2026-06-307.2B → 8.5B (+18.3% total)+2.89%2021-06-30 → 2026-06-307.4B → 8.5B (+15.3% total)+1.10%2016-12-31 → 2026-06-307.7B → 8.5B (+11.0% total)
Net income: -2.04%2025-06-30 → 2026-06-30823.4M → 806.6M (-2.0% total)+16.84%2023-06-30 → 2026-06-30505.6M → 806.6M (+59.5% total)-2.52%2021-06-30 → 2026-06-30916.2M → 806.6M (-12.0% total)+13.53%2016-06-30 → 2026-06-30226.7M → 806.6M (+255.8% total)
FCF: +3.45%2025-06-30 → 2026-06-301.5B → 1.5B (+3.4% total)+11.59%2023-06-30 → 2026-06-301.1B → 1.5B (+39.0% total)+1.65%2021-06-30 → 2026-06-301.4B → 1.5B (+8.5% total)+3.92%2016-06-30 → 2026-06-301B → 1.5B (+46.9% total)
Shares: -3.72%2025-06-30 → 2026-06-30198.1M → 190.7M (-3.7% total)-3.00%2023-06-30 → 2026-06-30209M → 190.7M (-8.7% total)-1.80%2021-06-30 → 2026-06-30208.8M → 190.7M (-8.7% total)-0.47%2016-06-30 → 2026-06-30200M → 190.7M (-4.6% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: -0.07%2025-06-30 → 2026-06-30$4.11 → $4.11 (-0.1% total)+19.56%2023-06-30 → 2026-06-30$2.40 → $4.11 (+70.9% total)-1.18%2021-06-30 → 2026-06-30$4.36 → $4.11 (-5.8% total)+13.99%2016-06-30 → 2026-06-30$1.11 → $4.11 (+270.2% total)
Sales/share: +12.82%2025-06-30 → 2026-06-30$39.55 → $44.61 (+12.8% total)+9.01%2023-06-30 → 2026-06-30$34.43 → $44.61 (+29.6% total)+4.77%2021-06-30 → 2026-06-30$35.33 → $44.61 (+26.3% total)+1.67%2016-12-31 → 2026-06-30$38.13 → $44.61 (+17.0% total)
FCF/share: +7.44%2025-06-30 → 2026-06-30$7.43 → $7.98 (+7.4% total)+15.03%2023-06-30 → 2026-06-30$5.24 → $7.98 (+52.2% total)+3.51%2021-06-30 → 2026-06-30$6.72 → $7.98 (+18.8% total)+4.41%2016-06-30 → 2026-06-30$5.18 → $7.98 (+54.0% total)
Book value/share: +4.68%2025-06-30 → 2026-06-30$63.23 → $66.18 (+4.7% total)+3.78%2023-06-30 → 2026-06-30$59.20 → $66.18 (+11.8% total)+1.90%2021-06-30 → 2026-06-30$60.23 → $66.18 (+9.9% total)+3.32%2016-06-30 → 2026-06-30$47.74 → $66.18 (+38.6% total)
Dividend/share: +0.00%2025-06-30 → 2026-06-30$0.96 → $0.96 (+0.0% total)+0.00%2023-06-30 → 2026-06-30$0.96 → $0.96 (+0.0% total)+0.00%2021-06-30 → 2026-06-30$0.96 → $0.96 (+0.0% total)+0.43%2016-06-30 → 2026-06-30$0.92 → $0.96 (+4.3% total)
Price: -7.37%2025-10-06 → 2026-10-05$98.83 → $91.57 (-7.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-5.73%2023-10-05 → 2026-10-05$109.30 → $91.57 (-16.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-8.37%2021-10-05 → 2026-10-05$141.76 → $91.57 (-35.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-3.10%2016-10-04 → 2026-10-05$125.47 → $91.57 (-27.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -6.37%2025-10-06 → 2026-10-05$97.78 → $91.57 (-6.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-4.83%2023-10-05 → 2026-10-05$106.24 → $91.57 (-13.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-7.55%2021-10-05 → 2026-10-05$135.61 → $91.57 (-32.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-2.29%2016-10-04 → 2026-10-05$115.47 → $91.57 (-20.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 22.3×2016-12 55.242026-10 21.65-60.8% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 14.5×2016-12 23.442026-10 14.49-38.2% over the window
Fwd P/E: 9.7×
P/S (ttm)Market cap ÷ TTM revenue.: 2.1×2016-12 4.702026-10 2.05-56.3% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 1.4×2016-12 2.062026-10 1.38-32.8% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 11.5×2016-12 15.582026-10 11.47-26.4% over the window
EV/EBITDA (fy): 10.7×
EV/Sales (ttm): 2.9×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 8.72%2016-09 6.4%2026-06 9.5%+47.5% over the window
Dividend yield (fwd)Indicated annual dividend ÷ last close: the last regular payment × payments a year, from our own dividend record. Shown only for a company that pays the same amount each time (raises and cuts allowed), whose payments are on schedule and agree with the dividends it reports paying; a company whose payments vary in size, such as an unequal interim and final, has no forward figure — see the ttm yield.: 1.05%
Dividend yield (ttm)Dividends paid over the last year ÷ last close: the last full cycle of regular payments in our own dividend record. Below the forward yield after a raise, above it after a cut. Shown only when the record holds that full cycle and it agrees with the dividends the company reports paying; otherwise —.: 1.05%
Dividend/share (fwd)The indicated annual dividend: the last regular payment × payments a year, for a company that pays the same amount each time.: $0.96
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 190.7M ÷ 198.1M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 3.72%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (3.72%) + dividends paid over that year ($188.4M) ÷ market_cap_at(2025-06-30) ($18.1B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 4.76%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($750.8M) ÷ today's market cap ($17.5B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 4.30%2016-09 2.8%2026-06 4.7%+65.7% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $750.8M + TTM dividends $188.4M) ÷ today's market cap ($17.5B). Same caveat as the cash buyback yield.: 5.38%2016-09 3.7%2026-06 5.8%+56.2% over the window

Vs own 10Y history

P/E: 20th
P/OI: 6th
P/S: 3rd
P/B: 4th
P/FCF: 2nd

Bar = where today’s multiple sits in ZBH’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-05#

+3.72%

-0.05%

-6.63%

+4.69%

YTD

+1.83%

-9.14%

-35.40%

Recent filings#

Sep 11Insider sale · Thornal Kevin R (Grp Pres-Global Business) sold 5,691 shares for $529K at $92.95
Sep 88-K · Directors or officers; compensation; Regulation FD disclosure
Sep 4Insider sale · Phipps Chad F (See remarks below.) sold 3,000 shares for $295K at $98.35
Aug 5Earnings · Earnings release — EPS $2.07 vs $2.01 est. (+3.0%); revenue $2.18B (+5% y/y) 2.5%
Aug 5Report · Quarterly report, Q2 2026 — revenue $2.18B (+5% y/y), net income $198.3M, EPS $1.03

All filings and insider trades →

Financial statements

Open full ZBH financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-0.54%	+0.02%
JNJ	Johnson & Johnson	-8.10%	-1.21%
ABBV	AbbVie Inc.	+3.63%	+1.12%
MRK	Merck & Co. Inc.	-7.18%	-3.30%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-4.67%	+1.80%
TMO	Thermo Fisher Scientific Inc.	+10.26%	+3.35%
AMGN	Amgen Inc.	-7.83%	-0.01%
GILD	Gilead Sciences Inc.	-4.22%	-0.08%

ZBH — Zimmer Biomet Holdings Inc. price, chart and key statistics